BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 98643)

  • 1. Latent residual tumor following external radiotherapy for prostate adenocarcinoma.
    Nachtsheim DA; Mcaninch JW; Stutzman RE; Goebel JL
    J Urol; 1978 Sep; 120(3):312-4. PubMed ID: 98643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External beam radiotherapy for adenocarcinoma of the prostate: a clinical followup.
    Kiesling VJ; McAninch JW; Goebel JL; Agee RE
    J Urol; 1980 Dec; 124(6):851-4. PubMed ID: 6777509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic biopsy after irradiation therapy for prostatic cancer.
    Scardino PT; Wheeler TM
    Urology; 1985 Feb; 25(2 Suppl):39-46. PubMed ID: 3918375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate biopsy after definitive treatment by interstitial 125iodine implant or external beam radiation therapy.
    Schellhammer PF; el-Mahdi AM; Higgins EM; Schultheiss TE; Ladaga LE; Babb TJ
    J Urol; 1987 May; 137(5):897-901. PubMed ID: 3106654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy for prostatic carcinoma: post-irradiation prostatic biopsy and recurrence patterns with long-term followup.
    Leach GE; Cooper JF; Kagan AR; Snyder R; Forsythe A
    J Urol; 1982 Sep; 128(3):505-9. PubMed ID: 6811767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of needle biopsy after irradiation for stage C adenocarcinoma of the prostate.
    Cox JD; Stoffel TJ
    Cancer; 1977 Jul; 40(1):156-60. PubMed ID: 406978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do prostatic biopsies 12 months or more after external irradiation for adenocarcinoma, Stage III, predict long-term survival?
    Cox JD; Kline RW
    Int J Radiat Oncol Biol Phys; 1983 Mar; 9(3):299-303. PubMed ID: 6404866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary observations on the results of combined temporary 192iridium implantation and external beam irradiation for carcinoma of the prostate.
    Bosch PC; Forbes KA; Prassvinichai S; Miller JB; Golji H; Martin DC
    J Urol; 1986 Apr; 135(4):722-5. PubMed ID: 3083116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definitive radiation therapy for prostatic carcinoma: Mayo clinic experience.
    Cupps RE; Utz DC; Fleming TR; Carson CC; Zincke H; Myers RP
    J Urol; 1980 Dec; 124(6):855-9. PubMed ID: 6777510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant radiotherapy following radical prostatectomy: results and complications.
    Gibbons RP; Cole BS; Richardson RG; Correa RJ; Brannen GE; Mason JT; Taylor WJ; Hafermann MD
    J Urol; 1986 Jan; 135(1):65-8. PubMed ID: 3079837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma of the prostate: local control with external beam radiation therapy.
    Gibbons RP; Mason JT; Correa RJ; Cummings KB; Taylor WJ; Hafermann MD; Richardson RG
    J Urol; 1979 Mar; 121(3):310-2. PubMed ID: 107328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients.
    Stamey TA; Kabalin JN; Ferrari M
    J Urol; 1989 May; 141(5):1084-7. PubMed ID: 2468796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of clinical local failure after radiation therapy for prostate carcinoma.
    Schellhammer PF; Kuban DA; el-Mahdi AM
    J Urol; 1993 Dec; 150(6):1851-5. PubMed ID: 8230518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of percentage of preradiation needle biopsies with adenocarcinoma and total radiation dose on the pathologic response of unfavorable prostate adenocarcinoma.
    Goldstein NS; Kestin LL; Vicini FA; Martinez AA
    Am J Clin Pathol; 2002 Jun; 117(6):927-34. PubMed ID: 12047145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen.
    Kabalin JN; Hodge KK; McNeal JE; Freiha FS; Stamey TA
    J Urol; 1989 Aug; 142(2 Pt 1):326-31. PubMed ID: 2473221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with supervoltage radiotherapy in carcinoma of the prostate: a preliminary report.
    Mollenkamp JS; Cooper JF; Kagan AR
    J Urol; 1975 Mar; 113(3):374-7. PubMed ID: 804044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential benefit of improved local tumor control in patients with prostate carcinoma.
    Kuban DA; el-Mahdi AM; Schellhammer PF
    Cancer; 1995 May; 75(9):2373-82. PubMed ID: 7536125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teletherapy for stage C adenocarcinoma of the prostate.
    Lupu AN; Petrovich Z; Corvalan J; Katske FA; Kaufman JJ
    J Urol; 1982 Jul; 128(1):75-8. PubMed ID: 7109076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial gold and external beam irradiation for prostate cancer.
    Boileau MA; Dowling RA; Gonzales M; Handel PH; Benson GS; Corriere JN
    J Urol; 1988 May; 139(5):985-8. PubMed ID: 3129584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy.
    Ray GR; Bagshaw MA; Freiha F
    J Urol; 1984 Nov; 132(5):926-30. PubMed ID: 6436511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.